Related Experiment Video

Updated: May 19, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA

Qingbo Lang1, Changquan Ling

  • 1Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.

Biochemical and Biophysical Research Communications
|September 4, 2012
PubMed

Insights

MicroRNA-124 (miR-124) suppresses hepatocellular carcinoma (HCC) growth by targeting PIK3CA. This study reveals miR-124 inhibits tumor progression by downregulating PIK3CA and the PI3K/Akt pathway.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators in cancer development.
  • MicroRNA-124 (miR-124) is frequently downregulated in hepatocellular carcinoma (HCC).
  • The tumor-suppressive mechanisms of miR-124 in HCC remain largely unelucidated.

Purpose of the Study:

  • To investigate the role of miR-124 in HCC tumorigenesis.
  • To identify novel molecular targets of miR-124 in HCC.
  • To elucidate the underlying mechanisms of miR-124-mediated tumor suppression.

Main Methods:

  • Utilized HepG2 cells for in vitro experiments.
  • Performed mRNA and protein expression analysis.
  • Conducted cell cycle analysis, proliferation assays, and xenograft animal studies.

Main Results:

  • Identified phosphoinositide 3-kinase catalytic subunit alpha (PIK3CA) as a direct target of miR-124.
  • Demonstrated that miR-124 overexpression suppresses HCC cell proliferation and induces G1-phase arrest.
  • Showed that miR-124 targets PIK3CA, leading to the downregulation of the PI3K/Akt/mTOR pathway and reduced tumor growth in vivo.

Conclusions:

  • miR-124 acts as a tumor-suppressive miRNA in HCC.
  • Targeting PIK3CA by miR-124 inhibits HCC progression.
  • Restoration of miR-124 may represent a potential therapeutic strategy for HCC.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...